Use of Teriparatide in preventing delayed bone healing and nonunion: a multicentric study on a series of 20 patients

BMC Musculoskelet Disord. 2023 Mar 11;24(1):184. doi: 10.1186/s12891-023-06278-0.

Abstract

Background: Delayed bone healing and nonunions represent a great challenge for the orthopedic surgeon. In addition to traditional surgical approaches, increasing attention is being given to the use of systemic anabolic therapy with Teriparatide, whose efficacy in preventing osteoporotic fractures is widely validated and whose application as a promoter of bone healing has been described but it is still debated. The aim of the study was to evaluate bone healing in a series of patients with delayed unions or nonunions treated with Teriparatide in conjunction with eventual appropriate surgical procedure.

Methods: Twenty patients with an unconsolidated fracture that were treated at our Institutions from 2011 to 2020 with Teriparatide were retrospectively included into the study. The pharmacological anabolic support was used off-label with a planned duration of 6 months; radiographic healing was evaluated at 1-, 3- and 6-months follow-up outpatient visits over plain radiographs. Also, eventual side-effects were registered.

Results: Radiographic signs indicative of favorable evolution of the bone callus were observed as early as at 1 month of therapy in 15% of cases; at 3 months, healing progression was appreciated in 80% of cases and complete healing in 10%; at 6 months, 85% of delayed and nonunions had healed. In all patients, the anabolic therapy was well tolerated.

Conclusions: In accordance to Literature, this study suggests that Teriparatide plays a potentially important role in the treatment of some forms of delayed unions or nou-nions, even in the presence of failure of hardware. The results suggest a greater effect of the drug when associated with a condition in which the bone is in an active phase of callogenesis, or with a "revitalizing" treatment which represents a local (mechanical and/or biological) stimulus to the healing process. Despite the small sample size and the variety of cases, the efficacy of Teriparatide in treating delayed unions or nonunions emerged, highlighting how this anabolic therapy can represent a useful pharmacological support in the treatment of such a pathology. Although the results obtained are encouraging, further studies, particularly prospective and randomized, are needed to confirm the efficacy of the drug, and define a specific treatment algorithm.

Keywords: Anabolic therapy; Bone metabolism; Delayed union; Fracture healing; Nonunion; Teriparatide.

Publication types

  • Multicenter Study

MeSH terms

  • Bone Density Conservation Agents* / therapeutic use
  • Fracture Healing
  • Humans
  • Osteoporotic Fractures* / drug therapy
  • Prospective Studies
  • Retrospective Studies
  • Teriparatide / therapeutic use
  • Treatment Outcome

Substances

  • Teriparatide
  • Bone Density Conservation Agents